Trust Company of Vermont’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-55,993
| Closed | -$5.56M | – | 1003 |
|
|
2019
Q3 | $5.56M | Sell |
55,993
-3,146
| -5% | -$299K | 0.45% | 73 |
|
|
2019
Q2 | $5.47M | Sell |
59,139
-2,355
| -4% | -$224K | 0.45% | 71 |
|
|
2019
Q1 | $5.8M | Sell |
61,494
-9,020
| -13% | -$789K | 0.5% | 66 |
|
|
2018
Q4 | $4.52M | Sell |
70,514
-5,299
| -7% | -$391K | 0.44% | 72 |
|
|
2018
Q3 | $6.78M | Buy |
75,813
+3,328
| +5% | +$294K | 0.57% | 60 |
|
|
2018
Q2 | $5.76M | Buy |
72,485
+2,314
| +3% | +$192K | 0.52% | 64 |
|
|
2018
Q1 | $6.26M | Buy |
70,171
+12,861
| +22% | +$1.23M | 0.59% | 55 |
|
|
2017
Q4 | $5.98M | Buy |
57,310
+5,010
| +10% | +$565K | 0.56% | 57 |
|
|
2017
Q3 | $7.63M | Buy |
52,300
+1,434
| +3% | +$195K | 0.76% | 44 |
|
|
2017
Q2 | $6.61M | Buy |
50,866
+4,168
| +9% | +$511K | 0.68% | 51 |
|
|
2017
Q1 | $5.81M | Buy |
46,698
+659
| +1% | +$78.9K | 0.63% | 54 |
|
|
2016
Q4 | $5.33M | Buy |
46,039
+2,348
| +5% | +$261K | 0.61% | 52 |
|
|
2016
Q3 | $4.57M | Buy |
43,691
+1,411
| +3% | +$153K | 0.57% | 61 |
|
|
2016
Q2 | $4.17M | Buy |
42,280
+79
| +0.2% | +$8.17K | 0.55% | 62 |
|
|
2016
Q1 | $4.22M | Buy |
42,201
+2,929
| +7% | +$302K | 0.59% | 59 |
|
|
2015
Q4 | $4.7M | Buy |
39,272
+412
| +1% | +$47.7K | 0.67% | 52 |
|
|
2015
Q3 | $4.2M | Buy |
38,860
+4,258
| +12% | +$528K | 0.65% | 51 |
|
|
2015
Q2 | $4M | Buy |
34,602
+2,053
| +6% | +$235K | 0.58% | 54 |
|
|
2015
Q1 | $3.75M | Buy |
32,549
+846
| +3% | +$101K | 0.55% | 59 |
|
|
2014
Q4 | $3.55M | Buy |
31,703
+358
| +1% | +$37.8K | 0.52% | 62 |
|
|
2014
Q3 | $2.97M | Buy |
31,345
+865
| +3% | +$78.1K | 0.45% | 70 |
|
|
2014
Q2 | $2.62M | Buy |
30,480
+2,394
| +9% | +$182K | 0.4% | 78 |
|
|
2014
Q1 | $1.96M | Buy |
28,086
+1,558
| +6% | +$123K | 0.32% | 91 |
|
|
2013
Q4 | $2.24M | Sell |
26,528
-2,234
| -8% | -$177K | 0.38% | 84 |
|
|
2013
Q3 | $2.22M | Buy |
28,762
+48
| +0.2% | +$3.36K | 0.41% | 83 |
|
|
2013
Q2 | $1.68M | Buy |
+28,714
| New | +$1.73M | 0.33% | 90 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Trust Company of Vermont's CELG Position: Q4 2019 in Review
Trust Company of Vermont sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 55,993 shares — an estimated $5.56M sold.
Trust Company of Vermont first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.63M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Trust Company of Vermont reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Trust Company of Vermont sold 55,993 Celgene Corp shares in Q4 2019, an estimated $5.56M.
- Trust Company of Vermont first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Trust Company of Vermont's Celgene Corp position peaked at $7.63M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Trust Company of Vermont's 13F filing for Q4 2019, filed 6 Feb 2020.